---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-005793"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:16:31.859368+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BD reorganizes into five segments; provides recast historical revenue data

## Summary
- New segments effective Oct 1, 2025: Medical Essentials, Connected Care, BioPharma Systems, Interventional, Life Sciences.
- Life Sciences segment to be eliminated after planned combination of Biosciences/Diagnostic Solutions with Waters Corp (announced July 13, 2025).
- Exhibit 99.1 furnishes recast segment revenues for FY2025 and quarterly periods, including non-GAAP measures.
- Segment reorganization does not affect principal product lines of any organizational unit.

## SEC filing metadata
- accession: 0001628280-26-005793
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828026005793/0001628280-26-005793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828026005793/bdx-20260205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-005793
- JSON: https://secwatch.observer/filing/0001628280-26-005793.json
- Plain text: https://secwatch.observer/filing/0001628280-26-005793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.